Nephrology News

Leflunomide is non-inferior to azathioprine in terms of safety and efficacy for lupus nephritis maintenance therapy, according to data published in the Annals of the Rheumatic Diseases.

Recent data has revealed a growing divide between rheumatologists and nephrologists in their therapeutic choices for patients with lupus nephritis, according to researchers from Spherix Global Insights.

Black adults showed a higher prevalence for gout than white adults during a 10-year period, even after adjusting for diet, social determinants of health and chronic kidney disease, according to data published in JAMA Network.

Compared with kidneys from deceased donors, organs from living donors show best graft survival in pediatric patients.

The FDA has approved GlaxoSmithKline’s belimumab for the treatment of children with active lupus nephritis who are also receiving standard therapy, according to a company press release.

PHILADELPHIA — In this Healio video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, discussed the recently published multidisciplinary guidelines for diabetes and cardio-renal-metabolic diseases.

Telemedicine offers the promise of increased efficiency during patient care, but in-person evaluations and relationships are too valuable to completely disregard, according to a debate session at EULAR 2022 Congress.

The HHS Office of Climate Change and Health Equity has launched Climate and Health Outlook, a new climate-related public health information series, according to a press release.

Children with lupus of all racial and ethnic groups have experienced reduced of end-stage renal disease and dialysis, but the overall improvement has failed to close the outcome gap between Black and white patients, researchers noted.

The first proposed definition for disease modification in systemic lupus erythematosus, including lupus nephritis, requires “minimizing” disease activity with few treatment-associated toxicities, while slowing organ damage progression.